ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,352Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 110

$682K Total Retail Price of All Prescriptions

Rank: 7 out of 110

203 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 203 patients filled at least one prescription for a schedule two drug, compared to an average of 10%.

Schedule Three
Controlled Substances

19% of this provider’s 203 patients filled at least one prescription for a schedule three drug, compared to an average of 22%.

Risky Drugs to Seniors

4% of this provider’s 7,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 5%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $86 among peers.

Prescriptions per Patient

66 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 859 590 1 2
SIMVASTATIN 725 463 2 3
RANITIDINE HCL 515 293 3 49
FUROSEMIDE 501 310 4 6
AMLODIPINE BESYLATE 489 331 5 5
METOPROLOL TARTRATE 480 370 6 9
POTASSIUM CHLORIDE 461 287 7 12
HYDROCHLOROTHIAZIDE 389 290 8 23
OMEPRAZOLE 373 212 9 8
METFORMIN HCL 363 154 10 18
LEVOTHYROXINE SODIUM 335 217 11 7
HYDROCODONE-ACETAMINOPHEN 302 123 S3 12 1
GABAPENTIN 296 145 13 4
GLYBURIDE 247 181 R 14 118
CITALOPRAM HBR 208 86 15 33
LEVEMIR 195 113 16 134
CRESTOR 194 131 17 19
DOXAZOSIN MESYLATE 187 148 18 77
LYRICA 186 87 19 30
CLOPIDOGREL 184 125 20 13
ACTOS 183 115 21 121
ISOSORBIDE MONONITRATE ER 173 119 22 29
IBUPROFEN 166 64 23 94
CARVEDILOL 162 127 24 9
LOSARTAN POTASSIUM 161 131 25 32
NITROSTAT 157 105 26 79
JANUVIA 154 97 27 119
PLAVIX 151 107 28 24
ADVAIR DISKUS 143 72 29 63
TRIGLIDE 143 116 10 29 158
FENOFIBRATE 141 91 31 160
GLIPIZIDE XL 124 86 32 174
SPIRIVA 123 84 33 82
NOVOLIN 70-30 109 83 34 184
GLIPIZIDE ER 98 49 35 152
TRAMADOL HCL 93 62 36 20
NIFEDIPINE ER 92 45 37 190
ALENDRONATE SODIUM 91 74 38 55
SPIRONOLACTONE 91 47 38 74
CYCLOBENZAPRINE HCL 83 21 R 40 69
AMITRIPTYLINE HCL 82 31 R 41 90
COMBIVENT 78 40 42 130
PROVENTIL HFA 78 35 42 200
TRIAMCINOLONE ACETONIDE 77 53 44 95
PROAIR HFA 74 34 45 47
GEMFIBROZIL 70 54 46 143
TRAZODONE HCL 68 37 47 68
ATENOLOL 67 23 48 69
ALLOPURINOL 65 27 49 40
THEOPHYLLINE ANHYDROUS 60 48 50 220
TRAVATAN Z 57 48 51 42
ATORVASTATIN CALCIUM 55 38 52 16
VERAPAMIL ER 54 23 53 239
FLUNISOLIDE 54 32 53 239
OXYBUTYNIN CHLORIDE 54 18 53 103
PREDNISONE 52 35 56 26
FLUOXETINE HCL 51 30 57 92
MELOXICAM 50 20 58 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.